Atlassian (NASDAQ:TEAM) CRO Sells $99,409.70 in Stock

Atlassian Corporation PLC (NASDAQ:TEAM) CRO Brian Duffy sold 1,222 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $81.35, for a total transaction of $99,409.70. Following the completion of the sale, the executive directly owned 124,332 shares of the company’s stock, valued at $10,114,408.20. The trade was a 0.97% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Atlassian Trading Down 5.3%

Shares of NASDAQ TEAM traded down $4.28 during midday trading on Friday, reaching $75.98. 9,550,965 shares of the stock were exchanged, compared to its average volume of 6,146,748. Atlassian Corporation PLC has a 12 month low of $75.01 and a 12 month high of $298.63. The company has a market capitalization of $20.04 billion, a price-to-earnings ratio of -105.53, a P/E/G ratio of 69.79 and a beta of 0.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.89 and a quick ratio of 0.89. The business has a 50-day simple moving average of $129.72 and a two-hundred day simple moving average of $150.72.

Atlassian (NASDAQ:TEAM) last posted its earnings results on Thursday, February 5th. The technology company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.10. Atlassian had a negative return on equity of 6.33% and a negative net margin of 3.29%.The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same period in the previous year, the company posted $0.96 earnings per share. The company’s revenue for the quarter was up 23.3% on a year-over-year basis. As a group, equities research analysts expect that Atlassian Corporation PLC will post -0.34 EPS for the current year.

Institutional Investors Weigh In On Atlassian

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Capco Asset Management LLC acquired a new stake in shares of Atlassian in the second quarter valued at about $25,000. Physician Wealth Advisors Inc. grew its stake in Atlassian by 60.4% in the third quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after purchasing an additional 61 shares in the last quarter. Geneos Wealth Management Inc. increased its position in shares of Atlassian by 447.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock worth $42,000 after purchasing an additional 161 shares during the last quarter. Atlantic Union Bankshares Corp raised its stake in shares of Atlassian by 19,900.0% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock worth $32,000 after purchasing an additional 199 shares in the last quarter. Finally, Board of the Pension Protection Fund acquired a new stake in shares of Atlassian in the 4th quarter valued at approximately $32,000. 94.45% of the stock is owned by institutional investors.

Key Atlassian News

Here are the key news stories impacting Atlassian this week:

• Positive Sentiment: LinkedIn’s CFO is joining Atlassian — an experienced finance executive hire that can bolster leadership depth and investor confidence. LinkedIn CFO jumps to Atlassian
• Positive Sentiment: A Seeking Alpha piece upgraded TEAM to “Strong Buy,” citing accelerating revenue growth, a rising RPO/backlog, high gross margins and improved pro forma operating margins — a fundamental read that supports a recovery thesis. Atlassian: Trust Growth Acceleration And RPO Buildup (Upgrade)
• Positive Sentiment: Coverage noting Q2 performance is driving optimism about Atlassian’s growth trajectory and backlog, reinforcing the view that recent share weakness is more sentiment-driven than fundamental. Second Quarter Performance Drives Optimism Around Atlassian (TEAM)
• Neutral Sentiment: Sector context — peers like RingCentral and Five9 rallied on AI-related positive results, showing mixed sentiment in software: some firms benefit from AI tailwinds while others face selling pressure. This is a market-level factor rather than a TEAM-specific catalyst. Beaten-down software stocks RingCentral and Five9 rally as earnings quell some AI concerns
• Neutral Sentiment: Reported short-interest data in the feed is anomalous (shows 0 shares / NaN changes) and provides no actionable signal; treat as unreliable until clarified by exchanges or official reports.
• Negative Sentiment: Multiple senior executives sold shares on Feb 19 (CFO Joseph Binz, CTO Rajeev Bashyam Rajan, CRO Brian Duffy, CAO Gene Liu). While these were relatively small percentages of holdings, clustered insider selling can raise investor concern on timing and outlook. SEC filings: SEC Filing — Joseph Leo Binz Sale SEC Filing — Rajeev Bashyam Rajan Sale SEC Filing — Brian Duffy Sale SEC Filing — Gene Liu Sale
• Negative Sentiment: Pomerantz LLP launched an investor investigation into Atlassian, which introduces legal/ reputational risk and can pressure shares while the inquiry proceeds. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atlassian Corporation – TEAM

Analyst Ratings Changes

Several brokerages have commented on TEAM. Macquarie Infrastructure dropped their target price on shares of Atlassian from $250.00 to $240.00 and set an “outperform” rating on the stock in a report on Monday, November 3rd. Barclays lowered their price objective on shares of Atlassian from $215.00 to $165.00 and set an “overweight” rating for the company in a research report on Friday, February 6th. UBS Group reaffirmed a “neutral” rating and issued a $105.00 price objective on shares of Atlassian in a research report on Friday, February 6th. Oppenheimer reduced their target price on shares of Atlassian from $275.00 to $150.00 and set an “outperform” rating for the company in a research note on Friday, February 6th. Finally, Citigroup lowered their target price on Atlassian from $210.00 to $160.00 and set a “buy” rating for the company in a report on Monday, February 9th. Twenty analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $189.32.

Atlassian Company Profile

Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.

Atlassian’s product portfolio centers on tools designed to help teams plan, build and support software and business processes.